Total zone transitions, NPP test

Total number of zone transitions during novelty place preference test for males and females [n]

Tags: Behavior · Motivation · Novelty

Project: p50_shelly_flagel_2014

2 loci · 2 genes with independent associations · 2 total associated genes

Significant Loci

# Chr Start pos End pos # assoc genes # joint models Best TWAS P Best GWAS P Cond GWAS P Joint genes
1 chr2 81659606 83054465 1 1 1.01e-07 4.31e-07 3.5e-01 Ankrd33b
2 chr8 108585012 109845634 1 1 9.01e-35 1.18e-03 1.0e+00 Klhdc8b

Pleiotropic Associations

Trait Chi2 ratio # genes+ # genes++ % genes++ Corr Corr P Genes
BMI with tail 18.84 1 1 50 0 1e+00 Klhdc8b
BMI without tail 27.06 1 1 50 0 1e+00 Klhdc8b
Body weight 20.7 1 1 50 0 1e+00 Klhdc8b
Heart weight 17.24 1 0 0 0 1e+00 Klhdc8b
Left kidney weight 27.97 1 1 50 0 1e+00 Klhdc8b
Right kidney weight 10.32 1 1 50 0 1e+00 Klhdc8b
Tail length 8.12 1 0 0 0 1e+00 Klhdc8b
Length with tail 9.26 1 1 50 0 1e+00 Klhdc8b
Length without tail 2.4 1 0 0 0 1e+00 Klhdc8b
Liver weight, left 13.45 1 0 0 0 1e+00 Klhdc8b
Liver weight, right 3.23 1 0 0 0 1e+00 Klhdc8b
Retroperitoneal fat weight 6.24 1 0 0 0 1e+00 Klhdc8b
Intraocular pressure 4.47 1 0 0 0 1e+00 Ankrd33b
Extensor digitorum longus weight 5.13 1 0 0 0 1e+00 Ankrd33b
Soleus weight 8.84 1 0 0 0 1e+00 Klhdc8b
Tibialis anterior weight 2.49 1 0 0 0 1e+00 Ankrd33b
Tibia length 7.46 2 1 50 0 1e+00 Ankrd33b Klhdc8b
Number of licking bursts 24.53 1 1 50 0 1e+00 Klhdc8b
Food consumed during 24 hour testing period 9.01 1 0 0 0 1e+00 Klhdc8b
Times rat made contact with spout 5.33 1 0 0 0 1e+00 Klhdc8b
Mean time between licks in bursts 5.14 1 0 0 0 1e+00 Klhdc8b
Mean num. licks in bursts 11.71 1 0 0 0 1e+00 Klhdc8b
Water consumed over 24 hours 8.34 1 0 0 0 1e+00 Klhdc8b
Patch foraging indifference point 0 sec 8.18 1 0 0 0 1e+00 Klhdc8b
Patch foraging indifference point AUC 4.75 1 0 0 0 1e+00 Klhdc8b
Indifference point function ln k 36.38 1 1 50 0 1e+00 Klhdc8b
Indifference point function log k 36.38 1 1 50 0 1e+00 Klhdc8b
Patch foraging total patch changes 0 sec 8.89 1 0 0 0 1e+00 Klhdc8b
Patch foraging total patch changes 18 sec 5.31 1 0 0 0 1e+00 Klhdc8b
Patch foraging total patch changes 24 sec 6.54 1 0 0 0 1e+00 Klhdc8b
Patch foraging time to switch 0 sec 6.73 1 0 0 0 1e+00 Klhdc8b
Locomotor activity 57.78 1 1 50 0 1e+00 Klhdc8b
Locomotor testing distance 64.52 1 1 50 0 1e+00 Klhdc8b
Locomotor testing rearing 3.38 1 0 0 0 1e+00 Klhdc8b
Light reinforcement 2 7.12 1 0 0 0 1e+00 Klhdc8b
Reaction time number correct 18.64 1 1 50 0 1e+00 Klhdc8b
Reaction time mean minus median 11.25 1 0 0 0 1e+00 Ankrd33b
Reaction time mean minus median AUC 6.29 1 0 0 0 1e+00 Ankrd33b
Reaction time num false alarms 5.75 1 0 0 0 1e+00 Klhdc8b
Reaction time num false alarms AUC 6.59 1 0 0 0 1e+00 Klhdc8b
Reaction time trials correct on left 18.64 1 1 50 0 1e+00 Klhdc8b
Reaction time trials on left 19.51 1 1 50 0 1e+00 Klhdc8b
Reaction time mean 7.32 1 0 0 0 1e+00 Ankrd33b
Reaction time mean AUC 7.91 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Median of all reaction times 10.54 1 0 0 0 1e+00 Klhdc8b
Reaction time omissions 23.75 1 1 50 0 1e+00 Klhdc8b
Reaction time false alarm rate 20.24 1 1 50 0 1e+00 Klhdc8b
Reaction time premature initiations 5.21 1 0 0 0 1e+00 Klhdc8b
Std. dev. reaction times 7.35 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Reaction time trials completed 19.51 1 1 50 0 1e+00 Klhdc8b
Reaction time trials AUC 20.65 1 1 50 0 1e+00 Klhdc8b
Conditioned locomotion 28.4 1 1 50 0 1e+00 Klhdc8b
Cocaine response after cond. not corrected 16.6 1 0 0 0 1e+00 Klhdc8b
Cocaine response before conditioning 38.66 1 1 50 0 1e+00 Klhdc8b
Saline control response 4.21 1 0 0 0 1e+00 Klhdc8b
Pavlov. Cond. magazine entry latency 5.33 1 0 0 0 1e+00 Klhdc8b
Pavlov. Cond. magazine entry number 30 1 1 50 0 1e+00 Klhdc8b
Pavlov. Cond. intertrial magazine entries 7.56 1 0 0 0 1e+00 Klhdc8b
Pavlov. Cond. response bias 5.18 1 0 0 0 1e+00 Klhdc8b
Conditioned reinforcement - inactives 16.77 1 0 0 0 1e+00 Klhdc8b
Conditioned locomotion 4.19 1 0 0 0 1e+00 Klhdc8b
Intermitt. access day 1 inactive lever presses 13.69 1 0 0 0 1e+00 Klhdc8b
Intermitt. access day 15 inactive lever presses 17.95 2 1 50 0 1e+00 Ankrd33b Klhdc8b
Intermittent access day 1 total infusions 7.02 1 0 0 0 1e+00 Klhdc8b
Intermittent access day 15 total infusions 14.21 1 0 0 0 1e+00 Klhdc8b
Intermittent access terminal intake (last 3 days) 24.03 1 0 0 0 1e+00 Klhdc8b
Intermittent access total infusions 15.45 1 0 0 0 1e+00 Klhdc8b
Intermittent access day 1 locomotion 8.57 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Intermittent access standard deviation 16.8 1 0 0 0 1e+00 Klhdc8b
Cocaine induced anxiety 13.65 1 0 0 0 1e+00 Klhdc8b
Lifetime Intake 9.49 1 0 0 0 1e+00 Klhdc8b
Progressive ratio test 1 active lever presses 7.99 1 0 0 0 1e+00 Ankrd33b
Progressive ratio test 1 breakpoint 7.6 1 0 0 0 1e+00 Ankrd33b
Progressive ratio test 1 inactive lever presses 16.55 1 0 0 0 1e+00 Klhdc8b
Progressive ratio test 2 active lever presses 4.8 1 0 0 0 1e+00 Klhdc8b
Progressive ratio test 2 inactive lever presses 10.83 1 0 0 0 1e+00 Klhdc8b
Total sessions with >9 infusions 16 1 0 0 0 1e+00 Klhdc8b
Short access day 1 total inactive lever presses 13.04 1 0 0 0 1e+00 Klhdc8b
Short access day 10 total inactive lever presses 101.65 1 1 50 0 1e+00 Klhdc8b
Short access day 10 total infusions 13.17 1 0 0 0 1e+00 Klhdc8b
Short access total infusions 5.11 1 0 0 0 1e+00 Klhdc8b
Short access day 1 locomotion 11.78 1 0 0 0 1e+00 Klhdc8b
One hour access (0.3 mA shock) 13.43 1 0 0 0 1e+00 Klhdc8b
One hour access (shock baseline) 8.36 1 0 0 0 1e+00 Klhdc8b
Locomotion velocity, session 1 6.86 1 0 0 0 1e+00 Ankrd33b
Locomotion distance, session 1 17.73 2 1 50 0 1e+00 Ankrd33b Klhdc8b
Locomotion velocity, session 2 7.78 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Locomotion distance, session 2 21.09 2 1 50 0 1e+00 Ankrd33b Klhdc8b
Locomotion velocity, session 3 17.14 1 0 0 0 1e+00 Klhdc8b
Locomotion distance, session 3 14.51 1 0 0 0 1e+00 Klhdc8b
Stereotopy head waving duration, day 3 6.96 1 0 0 0 1e+00 Klhdc8b
Locomotion velocity, session 8 7 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Locomotion distance, session 8 29.69 2 1 50 0 1e+00 Ankrd33b Klhdc8b
Degree of sensitization distance 24.75 1 0 0 0 1e+00 Klhdc8b
Condit. Reinf. active minus inactive responses 35.59 1 1 50 0 1e+00 Klhdc8b
Condit. Reinf. active-inactive response ratio 25.6 1 1 50 0 1e+00 Klhdc8b
Condit. Reinf. active responses 18.23 1 0 0 0 1e+00 Klhdc8b
Incentive salience index mean 26.23 1 1 50 0 1e+00 Klhdc8b
Condit. Reinf. lever presses 10.81 1 0 0 0 1e+00 Klhdc8b
Time in familiar zone, hab. session 1 63.49 1 1 50 0 1e+00 Klhdc8b
Time in novel zone, hab. session 1 13.1 1 0 0 0 1e+00 Klhdc8b
Total zone transitions, hab. session 1 26.61 2 1 50 0 1e+00 Ankrd33b Klhdc8b
Total locomotion distance, hab. session 1 8.83 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Locomotion velocity, hab. session 1 9.04 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Time in familiar zone, hab. session 2 27.1 1 1 50 0 1e+00 Klhdc8b
Time in novel zone, hab. session 2 10.13 1 0 0 0 1e+00 Klhdc8b
Total zone transitions, hab. session 2 43.5 2 1 50 0 1e+00 Ankrd33b Klhdc8b
Total locomotion distance, hab. session 2 12.38 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Locomotion velocity, hab. session 2 13.37 2 1 50 0 1e+00 Ankrd33b Klhdc8b
Novel to familiar place preference ratio 22.33 1 0 0 0 1e+00 Klhdc8b
Novelty place preference 20.99 1 0 0 0 1e+00 Klhdc8b
Time in novel zone, NPP test 17.06 1 0 0 0 1e+00 Klhdc8b
Total locomotion distance, NPP test 27.48 2 1 50 0 1e+00 Ankrd33b Klhdc8b
Locomotion velocity, NPP test 29.94 2 1 50 0 1e+00 Ankrd33b Klhdc8b
Pavlov. Cond. change in total contacts 69.48 1 1 50 0 1e+00 Klhdc8b
Pavlov. Cond. index score 14.07 1 0 0 0 1e+00 Klhdc8b
Pavlov. Cond. latency score 8.82 1 0 0 0 1e+00 Klhdc8b
Pavlov. Cond. lever contacts 4.86 1 0 0 0 1e+00 Klhdc8b
Pavlov. Cond. magazine entry number 12.23 1 0 0 0 1e+00 Klhdc8b
Pavlov. Cond. lever-magazine prob. diff. 14.82 1 0 0 0 1e+00 Klhdc8b
Pavlov. Cond. response bias 10.49 1 0 0 0 1e+00 Klhdc8b
Bone: cortical porosity 6.2 1 0 0 0 1e+00 Klhdc8b
Bone: elastic work 4.62 1 0 0 0 1e+00 Ankrd33b
Bone: endosteal estimation 3.3 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Bone: final force 4.4 1 0 0 0 1e+00 Klhdc8b
Bone: marrow area 2.96 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Bone: maximum diameter 3.26 1 0 0 0 1e+00 Klhdc8b
Bone: maximum force 7.19 1 0 0 0 1e+00 Klhdc8b
Bone: maximum moment 3.24 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Bone: periosteal estimation 3.34 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Bone: stiffness 13.41 1 0 0 0 1e+00 Klhdc8b
Bone: trabecular thickness 4.7 1 0 0 0 1e+00 Ankrd33b
Bone: trabecular tissue density 3.83 1 0 0 0 1e+00 Ankrd33b
Distance traveled before self-admin 7.55 1 0 0 0 1e+00 Ankrd33b
Delta time in closed arm before/after self-admin 12.84 1 0 0 0 1e+00 Klhdc8b
Extinction: sum of active levers before priming 5.93 1 0 0 0 1e+00 Klhdc8b
Active lever presses in extinction session 6 7.23 1 0 0 0 1e+00 Klhdc8b
Time in closed arm after self-admin 6.23 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Time in open arm after self-admin 4.99 1 0 0 0 1e+00 Ankrd33b
Time to tail flick, vehicle, after self-admin 37.57 1 1 50 0 1e+00 Klhdc8b
Delta time to tail flick, vehicle, before/after SA 14.47 1 0 0 0 1e+00 Klhdc8b
Ambulatory time before self-admin 6.17 1 0 0 0 1e+00 Ankrd33b
Ambulatory time after self-admin 6.07 1 0 0 0 1e+00 Klhdc8b
Total heroin consumption 18.89 1 0 0 0 1e+00 Klhdc8b
Area under the delay curve 5.07 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Delay disc. indifference point, 0s delay 28.7 1 1 50 0 1e+00 Klhdc8b
Delay disc. indifference point, 16s delay 13.12 1 0 0 0 1e+00 Klhdc8b
Delay disc. indifference point, 4s delay 41.82 1 1 50 0 1e+00 Klhdc8b
Delay disc. indifference point, 8s delay 5.59 1 0 0 0 1e+00 Klhdc8b
Delay discount exponential model param 5.63 1 0 0 0 1e+00 Ankrd33b
Delay discount hyperbolic model param 5.35 2 0 0 0 1e+00 Ankrd33b Klhdc8b
Fecal boli incidents, locomotor time 1 16.98 1 0 0 0 1e+00 Klhdc8b
Time >=10cm from walls, locomotor time 1 7.65 1 0 0 0 1e+00 Klhdc8b
Total resting periods, locomotor time 1 5.6 1 0 0 0 1e+00 Ankrd33b
Rest time, locomotor task time 1 22.55 1 0 0 0 1e+00 Klhdc8b
Distance moved, locomotor task time 1 31.01 1 1 50 0 1e+00 Klhdc8b
Vertical activity count, locomotor time 1 49.01 1 1 50 0 1e+00 Klhdc8b
Bouts of movement, locomotor time 2 19.85 1 0 0 0 1e+00 Klhdc8b
Total resting periods, locomotor time 2 20.22 1 0 0 0 1e+00 Klhdc8b
Rest time, locomotor task time 2 25.34 1 1 50 0 1e+00 Klhdc8b
Distance moved, locomotor task time 2 42.39 1 1 50 0 1e+00 Klhdc8b
Vertical activity count, locomotor time 2 54.92 1 1 50 0 1e+00 Klhdc8b
Weight adjusted by age 30.32 1 1 50 0 1e+00 Klhdc8b
Progressive ratio 7.25 1 0 0 0 1e+00 Klhdc8b
Food seeking constrained by brief footshock 12.71 1 0 0 0 1e+00 Klhdc8b
Seeking ratio, punishment vs. effort 4.64 1 0 0 0 1e+00 Klhdc8b
Run reversals in cocaine runway, females 6.51 1 0 0 0 1e+00 Klhdc8b
Cd content in liver 20.17 1 0 0 0 1e+00 Klhdc8b
Fe content in liver 40.39 1 1 50 0 1e+00 Klhdc8b
K content in liver 12.22 1 0 0 0 1e+00 Klhdc8b
Mg content in liver 15.79 1 0 0 0 1e+00 Klhdc8b
Mn content in liver 5.99 1 0 0 0 1e+00 Klhdc8b
Na content in liver 16.36 1 0 0 0 1e+00 Klhdc8b
Rb content in liver 51.88 1 1 50 0 1e+00 Klhdc8b
Se content in liver 8.45 1 0 0 0 1e+00 Klhdc8b
Sr content in liver 22.41 1 0 0 0 1e+00 Klhdc8b
Zn content in liver 9.95 1 0 0 0 1e+00 Klhdc8b

Associations by panel

Tissue RNA modality # hits % hits/tests Avg chisq
Adipose alternative polyA 0 0 1.42
Adipose alternative TSS 0 0 1.45
Adipose gene expression 0 0 1.46
Adipose isoform ratio 0 0 1.39
Adipose intron excision ratio 0 0 1.36
Adipose mRNA stability 0 0 1.45
BLA alternative polyA 0 0 1.35
BLA alternative TSS 0 0 1.44
BLA gene expression 0 0 1.46
BLA isoform ratio 0 0 1.39
BLA intron excision ratio 0 0 1.35
BLA mRNA stability 0 0 1.46
Brain alternative polyA 0 0 1.47
Brain alternative TSS 0 0 1.44
Brain gene expression 0 0 1.46
Brain isoform ratio 0 0 1.39
Brain intron excision ratio 0 0 1.37
Brain mRNA stability 0 0 1.45
Eye alternative polyA 0 0 1.55
Eye alternative TSS 0 0 1.35
Eye gene expression 0 0 1.47
Eye isoform ratio 0 0 1.36
Eye intron excision ratio 0 0 1.58
Eye mRNA stability 0 0 1.51
IL alternative polyA 0 0 1.32
IL alternative TSS 0 0 1.39
IL gene expression 0 0 1.51
IL isoform ratio 0 0 1.43
IL intron excision ratio 0 0 1.49
IL mRNA stability 0 0 1.43
LHb alternative polyA 0 0 1.38
LHb alternative TSS 0 0 1.36
LHb gene expression 0 0 1.45
LHb isoform ratio 0 0 1.33
LHb intron excision ratio 0 0 1.53
LHb mRNA stability 0 0 1.35
Liver alternative polyA 0 0 1.52
Liver alternative TSS 0 0 1.52
Liver gene expression 1 0 1.46
Liver isoform ratio 0 0 1.47
Liver intron excision ratio 0 0 1.34
Liver mRNA stability 0 0 1.43
NAcc alternative polyA 0 0 1.44
NAcc alternative TSS 0 0 1.4
NAcc gene expression 1 0 1.44
NAcc isoform ratio 0 0 1.39
NAcc intron excision ratio 0 0 1.42
NAcc mRNA stability 0 0 1.43
OFC alternative polyA 0 0 1.4
OFC alternative TSS 0 0 1.41
OFC gene expression 0 0 1.48
OFC isoform ratio 0 0 1.38
OFC intron excision ratio 0 0 1.46
OFC mRNA stability 0 0 1.43
PL alternative polyA 0 0 1.33
PL alternative TSS 0 0 1.37
PL gene expression 0 0 1.44
PL isoform ratio 0 0 1.38
PL intron excision ratio 0 0 1.38
PL mRNA stability 0 0 1.41
pVTA alternative polyA 0 0 1.38
pVTA alternative TSS 0 0 1.4
pVTA gene expression 0 0 1.5
pVTA isoform ratio 0 0 1.45
pVTA intron excision ratio 0 0 1.39
pVTA mRNA stability 0 0 1.43
RMTg alternative polyA 0 0 1.33
RMTg alternative TSS 0 0 1.49
RMTg gene expression 0 0 1.43
RMTg isoform ratio 0 0 1.37
RMTg intron excision ratio 0 0 1.37
RMTg mRNA stability 0 0 1.38